Add BrightSurf on Google Email

Difficult mood disorder successfully treated

A large-scale study has found lamotrigine to be safe and effective in preventing episodes of mood swings in patients with rapid-cycling bipolar disorder. The study, published in Journal of Clinical Psychiatry, showed that 41% of patients who received lamotrigine remained stable without relapse for six months, compared to 26% on placebo.

SourceUniversity Hospitals of Cleveland·JournalJournal of Clinical Psychiatry·DateDec 11, 2000

New front line treatment for advanced colorectal cancer

Researchers at Memorial Sloan-Kettering Cancer Center developed a new combination therapy of irinotecan, fluorouracil, and leucovorin that nearly doubled the tumor response rate and improved overall survival for patients with metastatic colorectal cancer. The study showed significant benefits with no increased incidence of serious side...

SourceMemorial Sloan Kettering Cancer Center·JournalNew England Journal of Medicine·DateSep 27, 2000

Encouraging results reported for new breast cancer therapy

A new treatment combination of paclitaxel and carboplatin has shown encouraging results in a clinical trial, achieving a 62% response rate and a projected 72% one-year survival rate. The treatment, which is compatible with prior anthracycline therapy, offers additional benefits for women with metastatic breast cancer.

SourceMayo Clinic·JournalCancer·DateFeb 7, 2000

Study suggests tailoring ADHD treatment

A new study finds that carefully monitored medication treatment alone can be as effective as combination therapy in reducing ADHD symptoms. The research recommends a personalized approach, combining optimal medication doses with monthly office visits and teacher input to maximize treatment effectiveness.

UPMC Study Shows What May Be The Most Effective Treatment For Depressed Elderly

A UPMC study of 124 depressed elderly participants found that a combination of medication and psychotherapy prevented depression recurrence in 80 percent of patients, while medication alone was effective in only 57 percent. The study suggests that continued treatment can significantly reduce the risk of recurrence.

SourceUniversity of Pittsburgh Medical Center·JournalJournal of the American Medical Association·DateJan 5, 1999

Depressed Americans Get Half The Care Canadians Do

A study of 574 Americans and 250 Canadians found that only a small fraction received appropriate depression treatment, with more Canadians receiving mental health services due to comprehensive national coverage. Patient attitudes, such as perception of need for help and fear of cost, also played a significant role in the disparity.

SourceCenter for Advancing Health·JournalJournal of General Internal Medicine·DateFeb 6, 1998

New Test May Improve Treatment Of Kidney Disease

A new test developed by Johns Hopkins researchers uses white blood cells to predict which medications are most effective for each patient with kidney disease. The study found a wide range of responses among patients, suggesting that such tests might assist physicians in developing personalized treatment strategies.

SourceJohns Hopkins Medicine·JournalThe Journal of Clinical Pharmacology·DateSep 16, 1997

Study Confirms That Combination Treatment Using A Protease Inhibitor Can Delay HIV Disease Progression And Death

A recent NIH study found that a combination of a protease inhibitor and two nucleoside analogue reverse transcriptase inhibitors can significantly reduce the occurrence of AIDS-defining illnesses or death. The study, ACTG 320, demonstrated improved survival and delayed disease progression in patients receiving triple combination therapy.